- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-715/20: Judgment of the General Court of 2 March 2022 — Degode- v EUIPO — Leo Pharma (Skinovea) (EU trade mark — Opposition proceedings — Application for the EU word mark Skinovea — Earlier national word mark SKINOREN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)
ECLI:EU:UNKNOWN:62020TA0715
62020TA0715
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
25.4.2022
Official Journal of the European Union
C 171/28
(Case T-715/20) (*)
(EU trade mark - Opposition proceedings - Application for the EU word mark Skinovea - Earlier national word mark SKINOREN - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
(2022/C 171/36)
Language of the case: English
Parties
Applicant: Degode-Dermago Development GmbH (Strausberg, Germany) (represented by: O. Spieker, A. Schönfleisch and N. Willich, lawyers)
Defendant: European Union Intellectual Property Office (represented by: M. Capostagno and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO: Leo Pharma A/S (Ballerup, Denmark)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 4 September 2020 (Case R 337/2020 5) relating to opposition proceedings between Leo Pharma and Degode-Dermago Development.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Degode-Dermago Development GmbH to pay the costs.
(*)
Language of the case: English
ECLI:EU:C:2022:140
* * *
(*) Language of the case: English.